Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes

European Journal of Pharmacology

Volumn 621, Issue 1-3, 2009, Pages 1-9

  Hie, Mamiko ^a   Yamazaki, Mariko ^a   Tsukamoto, Ikuyo ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

AP 1 (activator protein 1); c fos; c jun; Curcumin; Diabetes mellitus; Osteoclastogenesis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; COLONY STIMULATING FACTOR; CURCUMIN; GLUCOSE; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; PROTEIN C JUN; STREPTOZOCIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; BONE MARROW CELL; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEMALE; FEMUR; HISTOCHEMISTRY; INHIBITION KINETICS; INSULIN DEPENDENT DIABETES MELLITUS; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

ACID PHOSPHATASE; AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BONE MARROW CELLS; BONE RESORPTION; CALCIUM; CATHEPSIN K; CELL DIFFERENTIATION; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; EATING; FEMALE; FEMUR; GLYCOSURIA; HYDROXYPROLINE; ISOENZYMES; OSTEOCALCIN; OSTEOCLASTS; RATS; RNA, MESSENGER; STAINING AND LABELING; STEM CELLS; STREPTOZOCIN;

EID: 70349515164     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.08.025     Document Type: Article

References (34)

1. Ammon H.P., and Wahl M.A. Pharmacology of Curcuma longa. Planta Med. 57 (1991) 1-7
2. Arai F., Miyamoto T., Ohneda O., Inada T., Sudo T., Brasel K., Miyata T., Anderson D.M., and Suda T. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J. Exp. Med. 190 (1999) 1741-1754
3. Asagiri M., and Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 40 (2007) 251-264
4. Bergman I., and Loxley R. The determination of hydroxyproline in urine hydrolysates. Clin. Chim. Acta 27 (1970) 347-349
5. Bharti A.C., Takada Y., and Aggarwal B.B. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 172 (2004) 5940-5947
6. Bierhaus A., Zhang Y., Quehenberger P., Luther T., Haase M., Muller M., Mackman N., Ziegler R., and Nawroth P.P. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb. Haemost. 77 (1997) 772-782
7. Bjorgaas M., Haug E., and Johnsen H.J. The urinary excretion of deoxypyridinium cross-links is higher in diabetic than in nondiabetic adolescents. Calcif. Tissue Int. 65 (1999) 121-124
8. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
9. Chen Y.R., and Tan T.H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17 (1998) 173-178
10. Goto A., and Tsukamoto I. Increase in tartrate-resistant acid phosphatase of bone at the early stage of ascorbic acid deficiency in the ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rat. Calcif. Tissue Int. 73 (2003) 180-185
11. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., and Wagner E.F. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266 (1994) 443-448
12. Hanazawa S., Takeshita A., Amano S., Semba T., Nirazuka T., Katoh H., and Kitano S. Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268 (1993) 9526-9532
13. Harada S., and Rodan G.A. Control of osteoblast function and regulation of bone mass. Nat. Med. 423 (2003) 349-355
14. Hayashi S., Miyamoto A., Yamane T., Kataoka H., Ogawa M., Sugawara S., Nishikawa S., Nishikawa S., Sudo T., Yamazaki H., and Kunisada T. Osteoclast precursors in bone marrow and peritoneal cavity. J. Cell. Physiol. 170 (1997) 241-247
15. Hie M., Shimono M., Fujii K., and Tsukamoto I. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone 41 (2007) 1045-1050
16. Hofbauer L.C., and Heufelder A.E. Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J. Clin. Endocrinol. Metab. 85 (2000) 2355-2363
17. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Boyle W.J., and Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone Miner. Res. 15 (2000) 2-12
18. Kemink S.A., Hermus A.R., Swinkels L.M., Lutterman J.A., and Smals A.G. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J. Endocrinol. Investig. 23 (2000) 295-303
19. Krakauer J.C., McKenna M.J., Buderer N.F., Rao D.S., Whitehouse F.W., and Parfitt A.M. Bone loss and bone turnover in diabetes. Diabetes 44 (1995) 775-782
20. Kurihara N., Chenu C., Miller M., Civin C., and Roodman G.D. Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology 126 (1990) 2733-2741
21. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21 (2000) 115-137
22. McCabe L.R., Banerjee C., Kundu R., Harrison R.J., Dobner P.R., Stein J.L., Lian J.B., and Stein G.S. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology 137 (1996) 4398-4408
23. Notoya M., Nishimura H., Woo J.-T., Nagai K., Ishihara Y., and Hagiwara H. Curcumin inhibits the proliferation and mineralization of cultured osteoblasts. Eur. J. Pharmacol. 534 (2006) 55-62
24. Riggs B.L. The mechanisms of estrogen regulation of bone resorption. J. Clin. Invest. 106 (2000) 1203-1204
25. Sato T., Shibata T., Ikeda K., and Watanabe K. Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J. Bone Miner. Res. 16 (2001) 2215-2221
26. Selby P.L., Shearing P.A., and Marshall S.M. Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria. Diabetes Med. 12 (1995) 240-243
27. Squires M.S., Hudson E.A., Howells L., Sale S., Houghton C.E., Jones J.L., Fox L.H., Dickens M., Prigent S.A., and Manson M.M. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem. Pharmacol. 65 (2003) 361-376
28. Sudo T., Nishikawa S., Ogawa M., Kataoka H., Ohno N., Izawa A., Hayashi S., and Nishikawa S. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 11 (1995) 2469-2476
29. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20 (1999) 345-357
30. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50 (2001) 536-546
31. Thomas D.P., Sunters A., Gentry A., and Grigoriadis A.E. Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene. J. Cell Sci. 113 (2000) 439-450
32. Tuominen J.T., Impivaara O., Puukka P., and Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22 (1999) 1196-1200
33. Udagawa N., Takahashi N., Akatsu T., Tanaka H., Sasaki T., Nishihara T., Koga T., Martin T.J., and Suda T. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 7260-7264
34. Wang Z.Q., Ovitt C., Grigoriadis A.E., Möhle-Steinlein U., Rüther U., and Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature 360 (1992) 741-745